key: cord-0725317-w598ckbx
authors: Hakre, Shilpa; Elakhal Naouar, Ines; King, David B.; Burns, Jennifer L.; Jackson, Kenya N.; Krauss, Stephen W.; Chandrasekharan, Prabha; McCauley, Melanie D.; Ober Shepherd, Brittany L.; McHenry, Samantha; Bianchi, Elizabeth J.; Ouellette, Jason; Darden, Janice M.; Sanborn, Aaron D.; Daye, Sharon P.; Kwon, Paul O.; Stubbs, Jeremiah; Brigantti, Crystal L.; Hall, Tara L.; Beagle, Milford H.; Pieri, Jason A.; Frambes, Timothy R.; O’Connell, Robert J.; Modjarrad, Kayvon; Murray, Clinton K.; Jagodzinski, Linda L.; Scott, Paul T.; Peel, Sheila A.
title: Virological and serological assessment of U.S. Army trainees isolated for COVID-19
date: 2022-05-11
journal: J Infect Dis
DOI: 10.1093/infdis/jiac198
sha: ca75dd6c8abb6780eed4cec3aef96bfd6af83715
doc_id: 725317
cord_uid: w598ckbx

BACKGROUND: Laboratory screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a key mitigation measure to avoid the spread of infection among recruits starting basic combat training in a congregate setting. Since viral nucleic acid can be detected persistently after recovery, we evaluated other laboratory markers to distinguish recruits who could proceed with training from those who were infected. METHODS: Recruits isolated for coronavirus disease 2019 (COVID-19) were serially tested for SARS-CoV-2 subgenomic ribonucleic acid (sgRNA), and viral load (VL) by reverse transcriptase polymerase chain reaction (RT-PCR), and for anti- SARS-CoV-2. Cluster and quadratic discriminant analyses of results were performed. RESULTS: Among 229 recruits isolated for COVID-19, those with a RT-PCR cycle threshold >30.49 (sensitivity 95%, specificity 96%) or having sgRNA log10 RNA copies/mL <3.09 (sensitivity and specificity 96%) at entry into isolation were likely SARS-CoV-2 uninfected. Viral load > 4.58 log10 RNA copies/mL or anti- SARS-CoV-2 signal-to-cutoff ratio < 1.38 (VL: sensitivity and specificity 93%; anti- SARS-CoV-2: sensitivity 83%, specificity 79%) had comparatively lower sensitivity and specificity when used alone for discrimination of infected from uninfected. CONCLUSIONS: Orthogonal laboratory assays used in combination with RT-PCR may have utility in determining SARS-CoV-2 infection status for decisions regarding isolation.

included reductions in residential barrack size and training intake, restriction in movement after arrival, 6 structuring small groups for all activities, screening for SARS-CoV-2 at entry and exit from 14-day 7 quarantine at arrival, and isolation of recruits with suspected or confirmed COVID-19 based on medical 8 evaluation and laboratory evidence of infection. Quantitative viral ribonucleic acid (RNA) and subgenomic RNA (sgRNA) have been reported to be 7 good surrogate measures for infectivity among hospitalized patients.[11-15] Viral load (VL) ≥5 to 6 log 8 copies/mL has been associated with culture-based isolation of SARS-CoV-2 from the respiratory tract; 9 sgRNA demonstrated a 97% sensitivity, 94% positive predictive value, and greater odds (10.2, 95% CI 10 1.6-65.0) in detecting replication-competent virus compared to viral culture.[13, 16] We followed 11 recruits isolated for suspected or confirmed SARS-CoV-2 infection to evaluate whether discontinuation 12 of isolation and entry into training was possible based on results from non-culture based laboratory 13 assays.

Surveillance Design and Ethics 16 We surveyed recruits isolated for COVID-19 from October 14-November 23, 2020 at a basic 17 combat training (BCT) facility from entry (visit 1) until the end of isolation (visit 5). Recruits were 18 isolated for COVID-19 for either testing positive by RT-PCR screening at entry or exit from initial 19 arrival quarantine, or for having had exposure to COVID-19, or for clinical suspicion of COVID-19 20 upon medical evaluation. Screening assays in use by the facility during the surveillance period were 21 GeneXpert (Cepheid, Sunnyvale, CA) and Panther Fusion SARS-CoV-2 (Hologic, Inc., San Diego, CA) assays. Upon arrival at the training facility, recruits underwent daily symptom and temperature checks, 23 on the first day after arrival after which a quarantine or controlled-monitoring period of 14 days was 24 A C C E P T E D M A N U S C R I P T enforced in groups (or "cocoons") of 30 to 60-65 recruits. Recruits identified or suspected of having 1 COVID-19 were moved to separate housing for medical isolation. We collected nasopharyngeal swabs 2 every 72 hours and blood specimens and self-administered questionnaires at entry and exit from 3 isolation. Descriptive statistics were used to characterize demographic features of recruits at arrival for 6 training and serial measurements of total VL, sgRNA, and total antibody levels during isolation. Panther Fusion SARS-CoV-2 results in this analysis was 41.9. Viral load, sgRNA, and S/CO ratio 4 results were log base 10 (log10) transformed for normalization in analysis. Viral load and sgRNA results 5 of "Target not detected" were coded zero for descriptive statistics and one for log10 transformation. All 6 data management and analysis were conducted using SAS 9.4 Software and R Studio 4.0.3.

We collected 1168 nasopharyngeal swabs from 235 recruits who were isolated for suspected or 9 confirmed COVID-19 from October 14-November 23, 2020. A total of 227 recruits screened RT-PCR 10 positive at either entry or exit from initial arrival quarantine; 117 (52%) were screened using Panther 11 Fusion assay and 110 (48%) by GeneXpert assay. Among 8 recruits who screened negative, 2 recruits 12 had laboratory evidence of COVID-19 during follow-up; 1 had high SARS-CoV-2 antibody levels at 13 visit 1 and another had quantifiable viral load. Therefore, the analysis reported here included 229 14 recruits. Seven recruits were lost to follow-up before completing their final visit. Recruits were followed 15 an average 12.4 days ( Table 1) . A majority (204, 89%) of recruits were isolated within 1-4 days (mean 16 3.1) of screening positive (Table 1) . Most recruits were male (79%), from southern U.S. states (54%) 17 aged an average 22.6 years (range 18.0-39.0). Less than one third (31%) reported experiencing COVID-18 19-like symptoms either before or during isolation (Table 1) . Most common symptoms reported were 19 runny nose (12%), cough (12%), sore throat (11%), and loss of smell (11%).

At visit 1, almost one fifth (48, 21%) of recruits tested negative on Panther Fusion, 87 (38%) and 21 38 (17%) had undetectable sgRNA and viral load results, respectively, and 119 (52%) were seropositive.

Overall Panther Fusion RT-PCR positivity decreased during follow-up by 20% from visit 1 (181, 79%) 23 to visit 5 (138, 59%) with an average 9.3-fold increase in Ct values ( Figure 1A , SFigure 1).

Correspondingly, sgRNA and viral load levels during follow-up decreased an average 2.9-fold and 2.8-1 fold, respectively, ( Figure 1B , SFigure 1). The proportion of recruits who seroconverted increased 39% 2 during follow-up, from 52% (n=119/228) at visit 1 to 91% (198/216) at visit 5 with an average 36.4-fold 3 increase in S/CO ratio ( Figure 1C , SFigure 1). Among recruits who were seropositive, the proportion of 4 recruits with neutralizing titer results ≥1:160 rose minimally from 64% (76/118) at visit 1 to 68% 5 (135/197) at visit 5. 6 All laboratory markers differed significantly by self-reported symptoms (Kruskal-Wallis test, 7 p<0.05) (Figure 2 , STable 1). Overall, Ct and S/CO ratio values across visits were lower for recruits who 8 reported any symptoms compared to those who did not (mean: Ct -30.1 vs 31.8, S/CO -45.7 vs 78.6, 9 respectively). In addition, overall sgRNA and viral load levels across visits were higher for recruits with 10 symptoms compared to those who were asymptomatic (mean log10 copies/mL: sgRNA -2.4 vs 1.5, VL 11 -3.9 vs 2.8, respectively). CoV-2 uninfected and likely to have controlled and cleared the virus whereas recruits in clusters A and 21 C were considered infected and grouped as one.

Quadratic discriminant analysis identified 2 of 4 markers as having the highest sensitivity and 23 specificity for distinguishing infected from uninfected groups (Table 2) . A Panther Fusion Ct value

below 30.49 or sgRNA above 3.09 log10 copies/mL (1230.27 copies/mL) were suggestive of SARS-1 CoV-2 infection at similar and relatively high sensitivity (95%-96%) and specificity (96%) ( Table 2) .

2 Comparatively, antibody tests had the lowest sensitivity (83%-93%) and specificity (79%-89%) for 3 potentially discriminating SARS-CoV-2 infected from uninfected at an optimal threshold of less than 4 S/CO ratio 1.38 (log10 0.14). In applying sensitivity and specificity results from QDA, parallel testing 5 using RT-PCR and another assay improved sensitivity (99.2%-99.8%) compared to using RT-PCR alone 6 (95%) ( Table 3 ) and serial testing increased the specificity of RT-PCR (99.2%-99.8%) when combined 7 with another assay versus using RT-PCR testing alone (96%) ( Table 3) . Recruits isolated for COVID-19 who were predominantly asymptomatic, were evaluated for viral 10 genomic and sgRNA levels every 3 days for two weeks, alongside total SARS-CoV-2 antibody response 11 at entry and exit from isolation. Our analysis suggests that Ct values from qualitative RT-PCR testing We are grateful to the recruits who participated in this activity. We thank SPC Kamille DeLeon, Available at: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2 2-reference-panel-comparative-data. Accessed 1/20/2022 2022. 3 35. European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 21 4 April 2022. Available at: https://www.ecdc.europa.eu/en/covid-19/variants-concern. Accessed April 28 5 2022. 

Multiple COVID-19 Clusters on a University Campus -2 North Carolina

Opening of Large Institutions of Higher Education and 4

County-Level COVID-19 Incidence -United States

Overview of Testing for SARS-CoV-2 (COVID-19)

Virological assessment of hospitalized patients with 10 COVID-2019

Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 12 patients: a narrative review

Clinical, immunological and virological characterization of COVID-19 14 patients that test re-positive for SARS-CoV-2 by RT-PCR

A follow-up study shows that recovered patients with re-positive PCR 16 test in Wuhan may not be infectious

Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset